Respiratory

Financial barriers to asthma medications continue to compromise patient outcomes, increasing the risk of asthma attacks and emergency room visits, according to a recent analysis spanning 2011 to 2022.

Discover how a polygenic risk score enhances traditional methods for identifying undiagnosed COPD in at-risk populations, offering a significant step forward in diagnosis.

Researchers at Vanderbilt University Medical Center, the University of Michigan Medical School, and the Translational Genomics Research Institute (TGen) have made significant strides in understanding idiopathic pulmonary fibrosis (IPF), an incurable and progressive lung disease.

New research highlights a critical yet often overlooked connection: poor sleep quality significantly increases the risk of malnutrition among adolescents with cystic fibrosis (CF).

A recent cohort study analyzing RSV protection in infants born between October 2023 and March 2024 provides critical insights into uptake patterns of maternal vaccination and monoclonal antibody therapy.

A systematic review and meta-analysis evaluating antiviral medications for nonsevere influenza provides new insights into the optimal treatments for symptom relief and hospitalization risks, particularly for high-risk patients.

New clinical practice guidelines for tuberculosis (TB) treatment have been released, reflecting recent clinical trial data.

Los Angeles healthcare professionals face a growing crisis as wildfire smoke engulfs the region, posing severe health risks for millions.